Solvias AG one of the largest independent analytical testing, contract research, development and manufacturing companies, today announced a non-exclusive partnership with Enzymicals AG, one of the most experienced companies in Germany for in-vitro biosynthesis with biocatalytic process development and up-scaling expertise. This will enable customers of both partners access to alternative synthetic technology platforms for chemocatalysis and biocatalysis.
